SBIR/STTR Research Award

Herbal Angiogenesis Stimulator for Chronic Wound Healing

Award identifier 2ee84828f737be656cae4dd13a1b260814157c2a1d549d7ccde7bb54ae41bf7bAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$99,559

Program and phase

SBIR · Phase I

Award year

2003

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
SUNNY BIODISCOVERY INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
YZF7QJ8S3RL3
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Chronic wounds translate into daily suffering for 7 million elderly people in United States and Europe alone. Modern dressings, as used today, are insufficient for optimal treatment of these wounds because most often they do not include compounds actively promoting wound healing. Stimulation of angiogenesis (wound vascularization) is a key requirement and a logic therapeutic approach to chronic wound healing. However, wound dressings, which include proteinaceous angiostimulators, are disappointing, because these stimulators are highly labile and cannot be maintained in treatment sites at therapeutic levels. Here we propose to test for enhancement of wound healing a small and stable angiostimulatory and fibroblast stimulatory molecule isolated in our laboratory from a Chinese medicinal plant. Using planimetry and advanced histochemistry we will test the effect of this stimulator on the speed and completeness of wound closure and on the quality of the reepithelialized tissue in animal and chimera human skin models. Furthermore, we will determine the chemical structure of this molecule with NMR, mass spectrometry, elemental analysis and crystallography. Taken together, this project aims to provide the proof-of-principle that a small stable angiogenesis/fibroblast stimulator can significantly improve wound healing and lead to a novel, commercially viable therapy for the treatment of chronic wounds.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

7 SBIR/STTR records share this UEI (2000–2013). Reported award amounts total $1,519,526. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.